Pay in 4 interest-free payments of $71.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
exhibits 82-fold selectivity over CB1 receptor
LY2886721 is a BACE inhibitor used for the treatment of Alzheimer's Disease
It shows no activity against CDK1/2/5
anti-hyperglycaemic
8- and 20-fold selective versus JAK1 and JAK3
Dehydroandrographolide MPC exhibits 82-fold selectivity over CB1Dehydroandrographolide, isolated from Andrographis paniculata (Burm. F.) Nees (Chuan xin lian), is a novel TMEM16A inhibitor and possesses multiple pharmacological activities, including anti inflammation, anti cancer, anti bacterial, anti virus and anti hepatitis activity.
US$ 60.00
US$ 31.50
US$ 892.50
US$ 55.00
US$ 35.00
US$ 48.95
